CAYCE PARKER: Open Payments
NPI 1962187278 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 57 payments from 21 companies in 2025. Trend: 2023 $295 · 2024 $1,072 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $177 |
| ABBVIE INC. | 9 | $167 |
| Novo Nordisk Inc | 8 | $147 |
| Lilly USA, LLC | 5 | $113 |
| PFIZER INC. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Seqirus USA Inc | 2 | $50 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Exact Sciences Corporation | 2 | $38 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
Products named: VRAYLAR, MOUNJARO, FARXIGA, REXULTI, Wegovy, AIRSUPRA, ELIQUIS, TZIELD.
Industry payments across SC — which companies pay providers there.
